Clinical Trials Browser

Phase 1/2 × Interventional × Recurrent Squamous Cell Lung Carcinoma × Clear all

NCT02536495 2015-10-30

Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer

Phase 1/2 Withdrawn

Recurrent Squamous Cell Lung Carcinoma